Quantum Biology - When the Night Stops Being the Night

Artificial light at night (ALAN) is usually framed as a “sleep hygiene” issue or a blue‑light problem, and I think that framing is too small. From a physics and quantum‑biology perspective, ALAN fundamentally changes the light environment that human circadian biology, mitochondria, and the microbiome evolved to read as information.

When we change the spectrum, timing, and intensity of light at night, we are effectively rewriting the instructions that photons give to circadian clocks, electrons, structured water, and microbes. The aim of this piece is to make that upstream physics visible to clinicians by treating the night not as a lifestyle choice, but as a boundary condition for mitochondrial and circadian function.

Light as an information signal

In human biology, light is not just “brightness.” It is a structured physical signal with three key components: spectral composition (wavelengths), intensity (illuminance in lux), and timing relative to internal circadian phase.

Photons are detected primarily by intrinsically photosensitive retinal ganglion cells in the eye, which express melanopsin and are maximally sensitive around 480 nm in the blue–cyan range. These cells project directly to the suprachiasmatic nucleus (SCN) in the hypothalamus, which translates photon input into timing signals for hormone secretion, autonomic output, core body temperature, and the phase of peripheral clocks throughout the body.

In the ancestral environment, the SCN saw a sharp contrast: broad‑spectrum, high‑lux sunlight during the day and near‑complete darkness at night, with only dim, warm light from fire or the moon. Under ALAN, the SCN is exposed to a smear of low‑to‑high intensity light across the 24‑hour cycle, often with a blue‑enriched spectrum. The binary between “day” and “night” collapses into prolonged, irregular light exposure.

How bright is “too bright” at night?

This section is not my primary area of expertise, but based on current research the circadian system is highly sensitive to night‑time light levels. In controlled laboratory studies, ordinary room lighting of about 50–200 lux in the hours before bed significantly suppresses melatonin compared with dim conditions, with reductions of around 50–70% when people are kept in typical indoor evening light for several hours.

The threshold for effect is low. Melatonin suppression and phase shifts can occur in some individuals at 30–50 lux, levels many people would describe as “dim.” Population data suggest that people living in brighter outdoor night‑time environments tend to have later bedtimes, shorter sleep, and poorer sleep quality, echoing the lab findings at scale.

When we compare ALAN levels to natural night light, the contrast is stark. Typical starlight is on the order of 0.0001–0.001 lux; a clear full moon provides roughly 0.05–0.3 lux at ground level; candlelight is usually around 1–5 lux. In modern homes during “night‑time,” light levels often sit comfortably above 20–50 lux once you add bedside lamps, overhead spots, and standby LEDs; from the SCN’s perspective, that is not night, it is still a type of day.

Blue‑enriched light outside its native context

Lux is not the whole story. Spectral composition strongly shapes the circadian impact of a given light level. Melanopsin’s action spectrum peaks around 480 nm, so blue‑enriched light has a disproportionate effect on circadian timing and melatonin suppression compared with longer‑wavelength light at the same illuminance.

Modern LEDs and screens concentrate spectral power in this blue–cyan band and often provide relatively less red and infrared compared with sunlight. Natural daylight, by contrast, delivers blue in the context of a broad spectrum rich in red and infrared, and only during daytime hours.

Quantum biology gives a useful lens here. Blue photons are higher‑energy; they push faster electron transitions and increase oxidative pressure along the respiratory chain, while red and infrared photons are lower‑energy and support cytochrome c oxidase activity, nitric oxide signalling, and water structuring around respiratory complexes. During the day, the system expects a package of blue plus red/IR plus UV and uses that mixture to time metabolism and redox signalling; at night, it expects these external photons to fall away to almost zero.

ALAN, especially from blue‑enriched LEDs, breaks that pattern. We take a signal that belongs in daytime and inject it into biological night: the right signal at the wrong time. Unsurprisingly, this has knock‑on effects across human physiology.

Dim light at night: molecular and systemic effects

The sensitivity to night‑time light runs deep into molecular clocks. In rodent studies, dim light at night around 5 lux is enough to alter expression of core clock genes such as Per1 and Per2 in the SCN and in peripheral tissues like liver and adipose. These changes in clock gene expression are accompanied by altered feeding rhythms, impaired glucose handling, and increased body weight, even without major increases in caloric intake.​

Dim artificial light at night has also been shown to disrupt gene expression rhythms and growth patterns in seagrass, suggesting that high sensitivity to nocturnal light is a more general feature of biological timing systems, not just mammals. Human data line up with this. ALAN is linked with reduced and delayed melatonin secretion, circadian misalignment, shorter and lighter sleep, and higher risk of metabolic and cardiometabolic disease; shift work, which layers mistimed bright light on top of irregular sleep and meals, appears particularly harmful, but even modest domestic light levels can shift physiology.

From a biophysical standpoint, darkness at night looks like a deliberately low‑noise state. It allows coordinated reductions in ATP demand, activation of repair processes such as autophagy and mitophagy, and up‑regulation of antioxidant defences, with melatonin acting both as a hormone of darkness and a mitochondria‑targeted antioxidant. ALAN erodes that phase, blurring the timing and quality of these repair programmes.

ALAN, gut physiology, and the microbiome

The gut is a major peripheral clock system and home to dense microbial communities. Circadian disruption via ALAN influences the gut environment indirectly through changes in motility, hormone secretion, barrier function, and mucosal immunity.

Animal work shows that constant light or disrupted light–dark cycles reshape the composition of the gut microbiota in ways that promote metabolic dysfunction. In one model, constant 200‑lux light altered microbiome composition, impaired intestinal barrier integrity, increased circulating LPS, and worsened liver inflammation and steatosis—essentially promoting a NAFLD‑like phenotype. Studies in birds suggest ALAN alters melatonin synthesis and microbiome structure in ways that change basal thermogenesis, energy balance, and migration patterns.

Human microbiome data are more limited, but the mechanisms are there. The SCN and local gut clocks regulate motility, bile acid rhythms, and tight junction dynamics—key features of microbial habitat. The gut produces substantial melatonin and expresses light‑sensitive molecules also found in the skin, which may influence motility, barrier function, and microbial signalling. ALAN suppresses melatonin and disrupts circadian timing, changing when gut permeability peaks, when bile is delivered, when immune surveillance is highest, and likely the “light show” inside the microbiome itself.

Over time, microbial communities adapt to this new temporal niche. Diet is not the only upstream organiser of the microbiome; the light environment is another, and in some contexts may be more powerful. Clinically, this gives us a plausible route from “chronic artificial light at night exposure” to chronic gut symptoms and dysbiosis patterns that prove hard to shift: physics upstream of food.

What about moonlight?

Moonlight is often raised as a counterpoint: if light at night is so harmful, what about a full moon? Here the numbers matter. Clear full moonlight provides roughly 0.05–0.3 lux at ground level—hundreds to thousands of times brighter than starlight, but still orders of magnitude dimmer than a typical living room. Even “circadian‑friendly” indoor lighting rarely gets down into this range.

There is some evidence that human sleep tracks the lunar cycle, with field studies in communities with minimal electric light showing later bedtimes and slightly shorter sleep around the full moon. This suggests our ancestors probably did not sleep identically across the lunar month; it is plausible they extended waking activities or held particular rituals on bright full‑moon evenings and then slept more during darker phases. But the size of this effect is modest and constrained by very low lux levels; the circadian system evolved to handle a gentle, predictable modulation of darkness, not chronic 50–300 lux in bedrooms and living rooms.

Darkness in quantum‑biology terms

In quantum‑biology language, darkness is not “nothing”; it creates a specific physical state. Removing external photons removes a major source of environmental noise and allows internal, more coherent processes to dominate for a while.

In photosynthetic light‑harvesting systems, “dark states” are ways of parking energy so that less of it is immediately lost as light or heat, letting wave‑like quantum behaviour persist a bit longer. In human cells, night does not switch the engines off; it turns them down for maintenance. Mitochondria still burn fuel and produce heat during sleep, but more of their effort goes into repair, redox clean‑up, and rebuilding damaged components than into movement and conscious processing. Core body temperature typically falls by about 1 °C overnight, yet uncoupling and brown‑fat‑linked heat production remain active, so we keep generating warmth while using the darker, quieter phase to restore ourselves.

You can think of night‑time darkness as a reduction in photonic noise that lets mitochondrial fields, membrane potentials, and water structures sit closer to their coherent “sweet spot,” instead of being constantly kicked by blue‑rich photons. Melatonin is the chemical signature of that dark state. As light falls, melatonin rises, targets mitochondria as an antioxidant, stabilises membranes and electron transport, and supports repair processes such as synaptic pruning, autophagy, and mitophagy. Darkness plus melatonin form a coupled physical‑biochemical regime: fewer external “measurements” by photons, more internal order and integration.

ALAN pushes the system back towards continual excitation resulting in more decoherence, more ROS, and less clearly defined repair time.

Why blue‑blocking glasses may not be enough

Blue‑blocking glasses can meaningfully reduce melanopsin‑mediated responses to screens and lighting, but they do not automatically create biological darkness. If the room stays at 100–200 lux—which is common in homes with multiple LED spotlights—the circadian system is still seeing a strong daytime‑like signal, even if the spectrum is nudged.

They also do nothing for light reaching non‑ocular photoreceptors in the skin or for the simple issue of timing: if the environment remains bright deep into biological night, the phase relationship between light exposure and internal clocks remains off. Experimental work shows that even low‑to‑moderate‑intensity blue‑enriched light in the late evening can significantly suppress melatonin and delay circadian phase; reducing, but not fully removing, blue may therefore be insufficient, particularly in sensitive or unwell people.

This fits with the environmental emphasis coming from the quantum‑biology community: you cannot supplement or filter your way out of a fundamentally poor light environment. The intervention cannot stop at putting an optical filter over our eyes and screens. Those tools can help, but the real focus needs to be on reducing overall brightness (lux), shifting the colour of evening light towards warmer tones, and moving the timing of light exposure back toward true night. This is exactly where behaviour change gets difficult: it means re‑aligning with natural light–dark cues and deliberately limiting technologies and ALAN we have grown up with late into the evening. For many people, that level of change feels too big, which may be one reason why chronic conditions linked to circadian disruption often remain stubbornly resistant, even when standard dietary and lifestyle advice has already been tried.

Clinical implications and practical targets

For clinicians working with metabolic disease, mood disorders, chronic inflammatory conditions, dysautonomia, MCAS, or complex multi‑system cases, ALAN (and, I would argue, EMFs) should be treated as primary modifiable risk factors.

Practical, measurable starting points might include:

• Reducing evening illuminance below roughly 50 lux after sunset in main living spaces, and below 10 lux in the last 1–2 hours before sleep.

• Using low‑intensity, long‑wavelength (red/amber) light in the late evening, ideally at or below eye level.

• Achieving darkness in the bedroom with blackout curtains, eye masks, and covered LEDs, allowing only very dim light, ideally closer to moonlight.

• Setting much stricter boundaries around social media, TV, and screens after dark; blue‑blocking glasses and screen filters can help, but they cannot out‑perform a poor light environment.

• Anchoring this darkness to strong morning daylight exposure, which strengthens circadian rhythms and improves resilience to unavoidable light insults later in the day, practically, this means actively seeking natural morning light, ideally at sunrise.

From a research perspective, ALAN is a tractable way to explore quantum‑biological ideas in humans. It provides a clear link between physical parameters and downstream changes in mitochondrial redox state, clock gene expression, and microbiome structure

.

As many in the quantum‑biology community have pointed out, trying to optimise mitochondrial function, gut health, or nervous‑system stability while ignoring the light environment is like trying to build a house with no foundations.

Being aware of the artificial light environment is not just another a niche wellness trend. ALAN presents our biology with a persistent physical insult to the nocturnal environment that is already affecting, and will continue to affect, human health. The evidence is now strong that even modest increases in night‑time illuminance, especially when blue‑enriched and chronic, are enough to disrupt circadian organisation, mitochondrial signalling, and gut physiology in clinically meaningful ways.

Taking quantum biology seriously means restoring the physics of the night, not just telling people to “wind down before bed.” Darkness is data, lux behaves like a drug, and spectrum is a code. When we change those inputs, we do not just alter how the night looks; we change what the night means to every cell and microbe in the body.

If you’d like to explore quantum biology in more depth, including the real nuances, the hard facts and where the hype begins – you’re very welcome to join me on Substack. There I share more specialised content on quantum biology, practical guides for navigating complex chronic illness, and my broader work on natural wellness, from growing food and foraging to everyday tools for supporting your health.

https://benourished.substack.com/